state lines

In an effort to clarify existing rules and regulations—and create new ones—the FDA has announced its plans and priorities for compounding pharmacy in 2018. Scott Gottlieb, MD, FDA Commissioner says that “because of the profound public health implications,” compounding pharmacy is a “priority.”...